Abstract. Dose rate is an essential factor in radiobiology. As modern radiotherapy delivery 9 techniques such as Volumetric Modulated Arc Therapy (VMAT) introduce dynamic 10 modulation of the dose rate, it is important to assess the changes in dose rate. Both the rate of 
26
In similarity to treatment planning system display of dose, the second method displays dose 27 rate as color wash on top of the corresponding CT image, allowing the user to scroll through treatments, two consecutive DICOM control points (CPs) form one arc sector. As regulated in the 5 DICOM standard, in both IMRT and VMAT treatment, the MU rate is set at each DICOM control 6 point for the following arc sector by the linac. In the system used, the resulting delivery parameters, 7 such as arc sector weight, MU rate in MU per minute, gantry speed and MU per degree are 8 precalculated by the TPS and used by the developed tool. The TPS calculates these parameters taking 9 into account linac specific limitations, e.g. maximum gantry rotation speed, maximum MLC leaf 10 speed or maximum MU rate as set in the plan. Within clinical tolerances, these constraints are 11 assumed to be met by the machine. 12
Starting from an anonymized VMAT DICOM RT plan file, data is read into the TPS for 13 precalculation of MU rates and arc sector times as detailed above. Artificial test cases were defined in SMCP to validate the dose rate calculations. As a first test 28 case, a virtual cylindrical water phantom with a diameter of 20 cm as shown in figure 1 was generated 29 to create test plans with a fixed source to surface distance to mimic reference conditions as defined for 30 static fields (Almond and Biggs 1999). This phantom was used for dose rate calculations for artificial 31 plans, manually varying the MU rate over the course of an arc in the plan file. Visualization of this 3D plus time data set poses a challenge, as current TPS are not equipped with 7 time depended dose display routines. Therefore, the calculation tool developed provides a variety of 8 visualization modes, two of which have proven most useful and will be presented here. 9
To get a view of the dose rates expected in a treatment, the tool provides a statistical analysis 10 of dose rate over time, neglecting spatial information in the process. Data is presented as a 11 2D-histogram, showing the number of voxels receiving a certain dose rate in each arc segment. This 12 mode provides fast analysis of the dose rates expected in a treatment or may be applied to a 13 subvolume defined in the treatment structure set. 14 On the other hand, in 2D plus time mode, the "color wash" dose display mode is mimicked, 15 enhanced by a scrollable time dimension. Instead of dose, dose rates are shown to provide all 16 information about the spatiotemporal variations during the fraction delivery. Example displays for 17 different arc sectors in one slice of the clinical head and neck case are shown in figure 3 . As this mode 18 provides full spatial information, it is better suited for detailed analysis of the dose rate patterns 19 emerging in the treatment. 20 shown as white overlay. 3
Application 4
For the three test cases selected, table 4 shows the low dose rates encountered in all VMAT 5 treatments: While maximum dose rates exceed a ratio of 1 cGy/min = 1 MU/min to their 6 corresponding sector's MU rate, in each case most of the target volume receives dose rates in the 7 lower end of the dose rate spectra. In the conventionally fractionated head and neck and cranial 8 irradiations, mean PTV dose rate hardly exceeds 100 cGy/min. While being an indicator of the 9 generally low dose rates encountered, mean dose rates are of solely statistical nature as they include 10 both in-and out of field dose rates. Both the head and neck as well as the cranial test case feature MU rate modulation in blocks of 5 several arc sectors with dose rates following the pattern. On the contrary, the hypofractionated liver 6 case modulates both the MU rate and dose rate without any visible grouping. OAR dose rates 7 generally tend to be lower than those encountered in the PTV, while still showing maximum dose 8 rates at in-field heights in all of the test cases. In the liver case, the body diameter permits sparing of 9 the spinal cord for most of the two arcs. Most of the dose to the OAR is delivered by two high dose 10 rate peaks, showing the case of the spinal cord lying within the beam on the entry and exit side, 11 respectively. For the head and neck and cranial cases, maximum dose rates to the OAR rarely drop 12 below 100 cGy/min, despite exhibiting lower MU-and maximum dose rates per voxel. OAR dose 13 rates are within a smaller range than for the liver case, illustrated by the banding of medium dose rate 14 voxels in the OAR histograms of the head and neck and cranial cases. 15
Discussion

16
A new efficient tool was developed to analyze dose rates per arc sector using MC calculations. 17 Following the depth dose curve, dose rates vary from values expected at reference conditions, with a 18 small fraction of voxels even surpassing a one to one ratio between dose rate in cGy/min and MU rate 19 in MU/min at skin depths smaller than 10 cm. Despite a maximum MU rate set to 600 MU/min, 20
analysis of the clinical test cases using conventional fractionation showed a substantial fraction of 21 voxels receiving dose rates below 100 cGy/min. The setting of MU rate in a VMAT radiotherapy plan 22 merely defines a point of reference in a spectrum of dose rates encountered. Not only may the 23 machine lower the MU rate according to its limitations in VMAT treatments, rendering dose rates 24 encountered dependent on the number of arcs and gantry angle travelled (as between the 2-arc and 4-25 arc sample cases). But also looking at the clinical test cases revealed that only a small part of the 26 voxels in the target volume is irradiated with dose rates nearing a ratio of 1 cGy/min = 1 MU/min 27 even below the set maximum MU rate. The more complex the target shape and modulation of the 1 field shape, the larger the fraction of voxels irradiated at low dose rates becomes as shown by the 2 clinical head and neck case selected. These findings may have substantial implications for future 3 research. On one hand, when assessing relative effectiveness of different dose rates in VMAT, 4 radiobiological data correlated to the dose rates encountered needs to be applied. If research should 5
show a reduced effectiveness of lower dose rates or even a threshold for altered effectiveness in low 6 dose rates as it was described by Hall (Hall 1972 ) for cobalt irradiation, weighting of low dose rates 7 might be adjusted accordingly. Some dose rates may even be low enough for DNA repair to outweigh 8 radiation damage. This would change radiobiological effectiveness during and after phases of low 9 dose rate irradiation, possibly even affecting effectiveness of high dose rates applied afterwards. On 10 the other hand, application of the tool may resolve conflicting evidence. Radiobiological models may 11 be verified and clinical findings explained by the new insights provided. together. These may be used to provide a "deconvolution" of the spatio-temporal patterns of dose 29 rates in VMAT to apply fixed dose rate evidence to these de-facto modern standard treatment 30 techniques. It would be interesting to see radiobiological and clinical research interpret these values. 31
In clinical routine, these data could aid deciding between treatment modalities of different dose rates, 32 such as flattened versus flattening filter free beams or conventional versus hypofractionation. With the 33 advent of new fractionation schemes, knowledge about dose rates would allow to choose a 34 fractionation scheme tailored to the dose rates encountered in specific regions of interest. Radiation 35 effect to the tumor could be tailored according to dose rate models as could damage to each organ at 36 risk individually. As modelling of dose rate response evolves (Herr et al 2014) , this tool serves as an 37 insight into dose rates encountered in modulated radiotherapy treatments and hopes to aid and guide 38 further investigation. 39
Conclusion
40
A tool to analyze planned dose rate distributions with sub-second accuracy was successfully 41 developed and validated. Visualization is done via histogram distributions of dose rates in regions of 42 interest over a treatment fraction or 2D plus time display as color wash. Dose rates per arc segment 43 encountered in clinical VMAT cases show a continuous spectrum of dose rates with a mean value in 44 the lower part of the spectrum for both conventional fractionation and for a hypofractionated liver 45 case. Dose rate distributions in modulated radiotherapy can now be assessed, and will serve as input 46 for further radiobiological study. In the future, these data could aid deciding between treatment 47 modalities of different dose rates, such as conventional versus hypofractionation. Fractionation 1 schemes might even be tailored to the dose rates encountered in specific regions of interest. 2 3 Almond P R and Biggs P J 1999 AAPM ' s TG-51 protocol for clinical reference dosimetry of high-4 energy photon and electron beams 1847-70 5
